Clinical Trials Market Size Predicted to Reach US$79.9 Billion by 2030

The global clinical trials market is set to experience substantial expansion, with market size projected to reach approximately US$79.9 billion by 2030, up from US$52.5 billion in 2022, according to a comprehensive market report by Fairfield Market Research. The market is anticipated to witness a steady Compound Annual Growth Rate (CAGR) of 6.2% during the period from 2023 to 2030.

Driving Forces

The clinical trials markets growth is primarily attributed to several key factors:

  1. Increasing Prevalence of Chronic Diseases: The rising incidence of chronic diseases worldwide is driving the demand for novel drugs and therapies, spurring growth in the clinical trials market.
  2. Rising R&D Expenditures: Major market players are increasing their Research and Development (R&D) investments, contributing significantly to the industrys expansion.
  3. Phase III Dominance: In 2022, the phase III category dominated the market due to its widespread implementation. High costs and a growing trend of outsourcing are expected to further boost demand in this category.
  4. Interventional Studies: The interventional segment is projected to dominate the global clinical trials market, driven by the prevalence of new viral illnesses and technological advancements.
  5. Oncology Leading the Way: In 2022, the oncology category held the largest market share, fueled by ongoing cancer treatment research and the need for precision medicine.
  6. Clinical Trial Data Management Services: This category is witnessing significant growth due to the increasing number of clinical trials, advancements in monitoring technology, and strict regulations regarding data management and security.
  7. North America Dominance: North America is expected to account for the largest share of the global clinical trials market, driven by increased R&D efforts and technology adoption in clinical research.
  8. Expanding Presence in Asia Pacific: Asia Pacific is becoming a significant player in the clinical trials market, attracting biotechnology companies for research due to its substantial patient pool and efficient procedures.

Growth Determinants

Several key growth determinants are shaping the clinical trials market:

  1. Growing Disease Variation and Prevalence: Increasing disease incidence and diversity, especially in emerging nations, encourage clinical trials for new or rare diseases.
  2. Shift Toward Personalized Medicine: A shift toward personalized treatment is anticipated, leading to more drugs successfully passing through clinical trials and increased investment in this phase by the biopharmaceutical industry.
  3. Growing Drug Pipelines and R&D Investments: Pharmaceutical, biopharmaceutical, and medical device companies are investing heavily in R&D to develop innovative treatments, leading to increased demand for clinical trials.

Major Growth Barriers

Despite the positive outlook, the clinical trials market faces certain challenges:

  1. Patient Recruitment and Retention: Finding suitable patient populations, especially for rare diseases, is challenging, along with patients lack of awareness and understanding of clinical trials.
  2. Lack of Skilled Workforce: Clinical research organizations (CROs) struggle to attract and retain qualified personnel, which can hinder the adoption of new technologies.

Key Trends and Opportunities

The clinical trials market is witnessing trends and opportunities such as:

  1. Augmented R&D Investments: Continued funding for innovative drugs and technologies from pharmaceutical and biotech companies.
  2. Favorable Outlook for Biologics and Biosimilars: Increasing focus on developing pharmaceuticals and biological substances.
  3. Increasing Collaborations in Biomedical Research: Collaboration among biopharmaceutical companies to share resources and reduce development costs.

Regulatory Scenario

The adoption of best practices and uniform standards across regions enhances clinical data credibility and regulatory acceptance. Regulatory bodies like the FDA in the US, the European Union, and the World Health Organization provide guidelines for conducting clinical trials.

Regional Frontrunners

  • North America: The United States, with its robust pharmaceutical industry, regulatory structure, and high disease prevalence, is expected to lead market growth in North America.
  • Asia Pacific: The Asia Pacific region is set to grow rapidly due to its accessible patient pool, government funding, and increasing healthcare needs.

Competitive Landscape

The global clinical trials market is competitive, with major players expanding their product offerings and distribution networks. Market consolidation is expected to continue in the coming years.

Global Clinical Trials Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 -(By Phase Coverage, By Study Design Coverage, By Indication Coverage, By Service Type Coverage, By Geographic Coverage and Leading Companies)

Visit Our Blogs:

About Us

Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.


Fairfield Market Research

London, UK

UK +44 (0)20 30025888

USA (Toll-free) +1 (844) 3829746



LinkedIn | Twitter

This press release first seen on Brilad

comtex tracking


Post Disclaimer

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Brite View Research journalist was involved in the writing and production of this article.